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Abstract
Background: Obligate intracellular pathogens belonging to the Chlamydiaceae family possess a
number of mechanisms by which to manipulate the host cell and surrounding environment. Such
capabilities include the inhibition of apoptosis, down-regulation of major histocompatability
complex (MHC) and CD1/d gene expression, and the acquisition of host-synthesized nutrients. It
is also documented that a limited number of host-derived macromolecules such as β-catenin and
sphingomyelin accumulate within the inclusion.
Results:  This report provides evidence that immunoglobulin, inherently present in the
extracellular environment in vivo and in vitro, enters infected cells and accumulates within the
chlamydial inclusion. Using epi-fluorescent and confocal microscopy, this selective uptake of Ig is
shown to occur among human leukocytes in vivo as well as cells cultured in vitro. These findings were
confirmed by detection of IgG in the lysate of infected cells by western blot hybridization.
Sequestered antibodies appear to be present during the entire course of the chlamydial
developmental cycle and are distributed throughout this compartment. IgG pre-labeled with
fluorescein, when added to the supernatant of infected cell cultures, was also imported and readily
visualized. Accumulation of these molecules within the inclusion and the failure of bovine serum
albumin or F(ab')2 fragments to accumulate in a similar manner suggests the process of entry is
specific for intact IgG molecules and not a result of pinocytosis, diffusion, or any other mass
endocytic event.
Conclusion: Sequestration of a host cell-derived protein within the chlamydial inclusion, although
unexpected, is not an unprecedented occurrence. However, selective accumulation of an
exogenous host protein, such as extracellular IgG, has not been previously reported in connection
with chlamydial infections. The selectivity of this process may indicate that this uptake plays an
important role in pathogen physiology or virulence during infection and the phenomenon itself may
give rise to novel diagnostic and therapeutic approaches.
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Background
Chlamydia trachomatis and Chlamydophila pneumoniae are
ubiquitous, obligately intracellular human pathogens
associated with ocular and respiratory tract infections,
respectively. C. trachomatis is also the leading cause of bac-
terial sexually transmitted disease and represents the most
commonly reported infectious agent in the United States,
estimated to account for over $2 billion in domestic
health care costs annually[1]. Additionally, strengthening
links between these organisms and chronic diseases such
as atherosclerosis, reactive arthritis, late-onset Alzhe-
imer's, and asthma make advances in the understanding
and treatment of these infections crucial for improved
public health [2-5].
Members of the Chlamydiaceae family occupy and modify
a membrane-bound vacuole termed an inclusion that has
traditionally been believed to minimize their interaction
with immune defenses and other host-derived molecules.
As a result, this would reduce exposure to bacteriocidal
factors and provide favorable conditions for chlamydial
development. While perceived as privileged, a limited
number of host macromolecules are known to be con-
tained within the chlamydial inclusion, examples being β-
catenin, sphingomyelin, CD63, and intermediate fila-
ment proteins [6-10]. It is also clear that several proteins
associated with key aspects of infection, such as pathogen
entry, do not localize within the inclusion; caveolin-1 and
2 are two such examples[11,12]. Similarly, many host
peptides, including several Rab GTPases, associate with
the inclusion membrane but do not enter the compart-
ment[13]. Although the trafficking mechanisms involved
for most of these inclusion-associated host proteins
remain to be fully characterized, it is clear that the scarcity
of intra-inclusion host proteins and the exclusion of key
molecules suggest that the contents of this compartment
accumulate selectively. Further evaluation of this privi-
leged site, the types of host proteins within it, and the
mechanisms by which they were sequestered will enhance
understanding of chlamydial infections and may give rise
to new methods for drug delivery and identification of
infected cells.
Results
In vitro Detection of intracellular immunoglobulin within 
Chlamydia-infected cells
IgG sequestration within the chlamydial inclusion was
first examined using cultured cell lines, conducted using
J774A.1 murine macrophages infected with C. trachomatis
serovar K. These in vitro experiments are based on the
intra-inclusion sequestration of bovine IgG, a component
of fetal bovine serum (FBS) that is routinely used as a sup-
plement to tissue culture medium. The data yielded from
these studies have indicated that extracellular IgG
becomes co-localized with the chlamydial inclusion dur-
ing infection.
In initial experiments, infected J774A.1 cells were fixed
and stained for detection of Chlamydia and bovine IgG. As
shown in Figure 1, coverslips immunostained at 24, 48,
and 72 hours post infection (hpi) demonstrate that IgG is
present within inclusions during both early and late stages
of the developmental cycle. In contrast, uninfected cells in
the same cultures (as observable at 48 hpi) show little to
no evidence of intracellular bovine IgG. Cells stained only
for Chlamydia failed to fluoresce in the FITC-channel, rul-
ing out overlap of emission spectra as the cause of appar-
ent IgG translocation (Additional File 1). The uptake of
IgG has also been observed in cells infected by C. trachom-
atis serovar L2 and C. pneumoniae, the latter providing ini-
tial evidence that this occurs among both genera of
Chlamydiaceae (data not shown). Although the exact cause
and effect of such accumulation is unclear, internalization
of IgG from the microenvironment surrounding infected
cells could impact the efficacy of the host humoral
response and/or play a role in chlamydial physiology.
It is important to note that visualization of nucleic acid
with 4',6-diamidino-2-phenylindole (DAPI) confirms
that the nuclei of uninfected and infected host cells are
intact. Their healthy appearance indicates that the uptake
of exogenous IgG by infected cells is not occurring due to
porous cell membranes, breakdown of other cellular com-
ponents, or as a function of impending cell lysis or death.
The low level of IgG in neighboring uninfected cells and
the observation that sequestered IgG is always associated
with the presence of inclusions support the theory that
these accumulations are a result of chlamydial infection.
Co-localized IgG is contained within the chlamydial 
inclusion
Initial observations of IgG co-localization with the inclu-
sion by epi-fluorescent microscopy led to evaluation of
this phenomenon by optical sectioning of J774A.1 mon-
olayers infected with C. trachomatis serovar K. A represent-
ative cross-sectional Z-axis series at 48 hpi was obtained
using confocal microscopy and examined for internalized
IgG (Fig. 2). These sections confirm that accumulated IgG
localizes inside the chlamydial inclusion. Having pro-
vided verification that IgG is within the inclusion, the
cross-sectioning of this and other cells excludes the possi-
bility that nonspecific surface binding or autofluorescence
led to the co-localization observed in the preceding exper-
iments. Analysis of the inclusion using Z-axis sectioning
also indicates that IgG is distributed throughout this
entire compartment. When images of immune-labeled
IgG and Chlamydia are merged (yellow), this distribution
is apparent due to the presence of FITC-labeled IgG stain-BMC Microbiology 2008, 8:213 http://www.biomedcentral.com/1471-2180/8/213
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IgG is present throughout the course of infection Figure 1
IgG is present throughout the course of infection. Selected time points throughout the course of a 72 h C. trachomatis 
serovar K infection in J774A.1 macrophages each show IgG to be co-localized with the chlamydial inclusion. FITC-labeled anti-
bovine IgG antibodies (green) heavily co-localize with TRITC-labeled chlamydial antigens (red) at all observed timepoints, sug-
gesting IgG is present during various stages of the chlamydial developmental cycle. A typical uninfected cell, detected by DAPI 
staining, is evident in the merge panel of the 48 hpi series and shows no antigen-specific recognition by the rabbit anti-Chlamy-
dia or goat anti-bovine IgG antibodies. (bar = 15 μm).BMC Microbiology 2008, 8:213 http://www.biomedcentral.com/1471-2180/8/213
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ing at the same locations as chlamydial antigens in all
cross-sections.
Confirmation of IgG sequestration by additional methods
The possibility that intra-inclusion IgG sequestration
observed during in vitro infection was an artifact of the cul-
ture system led to confirmatory experiments using alterna-
tive methods. Human leukocytes capable of supporting
chlamydial infection were evaluated after preparing
smears of donor blood samples. Using methods similar to
those applied to cell culture monolayers, these were
immunostained for chlamydial antigens and human IgG.
Microscopic examination of the samples indicated that
chlamydial antigens and IgG were exclusively co-local-
ized. Figures 3A and 3B consist of blood smears from two
different donors, each containing three leukocytes per
field. Immunolabeled human IgG (FITC, green) is detect-
ably co-localized with anti-Chlamydia  staining (TRITC,
red). Nomarski DIC imaging (insets) and nuclear (DAPI,
blue) staining indicate that the blood smears are well-pre-
served (also see additional 2). Thus, fragile erythrocytes in
the same field that are often subject to rupture, remain
intact. An example of an infected leukocyte is also
included with each Nomarski DIC image and confirms
that the membranes of these cells are also intact. The abil-
ity for a number of these cell types to become infected in
Bovine IgG is sequestered within the chlamydial inclusion Figure 2
Bovine IgG is sequestered within the chlamydial inclusion. Merged images from a cross-sectional Z-series of a repre-
sentative J774A.1 macrophage infected with C. trachomatis shows IgG distributed throughout the entire inclusion. Starting from 
the medial portion of the cell and sectioning downwards in 1 μm increments, co-localization (yellow) of chlamydial antigens and 
bovine IgG is observed throughout the thickness of the inclusion, indicating that IgG is contained within this compartment. For 
orientation, an "N" demarcates the nucleus that has been cross sectioned in the lowermost slice. Chlamydial organisms were 
labeled with a polyclonal rabbit anti-Chlamydia antibody and detected with TRITC-conjugated goat anti-rabbit IgG. IgG was 
labeled using a FITC-conjugated F(ab')2 goat anti-bovine IgG. (bar = 10 μm, section thickness = 0.5 μm)BMC Microbiology 2008, 8:213 http://www.biomedcentral.com/1471-2180/8/213
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vivo was previously demonstrated and quantified but no
reports have indicated that there is differential susceptibil-
ity[14]. This suggests that Chlamydia may be capable of
infecting IgG-producing plasma cells, which would result
in the apparent co-localization of human IgG within the
inclusion. However, studies evaluating the peripheral
blood of healthy patients in comparison to those with
multiple myeloma have indicated that normal donors do
not have detectable circulating plasma cells, which are pri-
marily located in lymph nodes[15].
Micrographs indicating that extracellular IgG is seques-
tered within Chlamydia-infected cells were corroborated
by examining their IgG content using western blot hybrid-
ization (Fig. 3C). To compare levels of IgG contained
within matched cultures of uninfected and infected cells,
flasks were treated with trypsin to lift cells and remove sur-
face-associated IgG. After thorough washing and lysis,
these preparations were analyzed and provided validation
for the immunofluorescent microscopy that had been per-
formed. The polyclonal anti-bovine IgG antibody used to
probe cell lysates detected high levels of intracellular IgG
in infected cell lysates but failed to detect the same prod-
uct in uninfected ones of matched cell number. This was
evident through the appearance of an IgG-positive band at
~4 kDa in infected cell lysates, an apparent product of IgG
breakdown, while uninfected J774A.1 cells contain a level
of intracellular IgG that is undetectable.
To ensure that cross-reactive binding of the anti-bovine
IgG antibody is not occurring during western blot analy-
sis, purified C. trachomatis elementary bodies were probed
simultaneously. The absence of any IgG-positive band in
this lane indicates that the antibody has no reactivity with
chlamydial organisms themselves.
Sequestration of extracellular IgG is selective
Based on the observations described, the potential selec-
tivity and specificity of protein uptake into the chlamydial
inclusion by infected cells was also evaluated. Fetal bovine
serum (FBS), the source of IgG sequestered within the
inclusion of cells in vitro, also contains the osmoregula-
tory protein bovine serum albumin (BSA). At ~66 kDa,
this protein is less than half the molecular weight of IgG
and present in ≥ 50-fold higher concentration, constitut-
ing more than 50% of the total protein in FBS. Because of
its abundance and low molecular weight relative to IgG,
infected cells were immuno-probed for BSA as a control
designed to assess the selectivity of the phenomenon.
Monolayers of J774A.1 cells infected with C. trachomatis
serovar K were incubated as in previous experiments and
probed to identify chlamydial antigens and BSA. Epi-fluo-
rescent microscopy indicates that BSA does not accumu-
late within the chlamydial inclusion as observed with IgG
(Fig. 4). The exclusion of BSA is significant because,
should IgG uptake occur by nonselective mechanisms
such as pinocytosis, diffusion, or phagocytosis, BSA
would be susceptible to the same phenomenon. There-
fore, the failure of BSA to enter infected cells supports the
conclusion that IgG sequestration is a selective process,
rather than a result of mass, non-specific endocytosis. Bio-
logical systems with analogous specificities typically
Confirmation of IgG accumulation by additional methods Figure 3
Confirmation of IgG accumulation by additional 
methods. Blood smears from two human donors, both with 
laboratory-confirmed chlamydial infections, were immunos-
tained for Chlamydia (TRITC, red) and human IgG (FITC, 
green). Microscopy fields A and B contain three unidentified 
leukocytes each, two of which are infected and representa-
tive of all infected white cells observed in vivo. Probing with a 
monoclonal mouse anti-human IgG antibody (detected using 
FITC-conjugated goat anti-mouse IgG) demonstrates that 
detectable levels of human IgG are present in infected leuko-
cytes. Yellow coloration represents instances of co-localiza-
tion between IgG and chlamydial inclusions. Inclusions were 
labeled with a rabbit anti-Chlamydia polyclonal antibody fol-
lowed by TRITC-conjugated goat anti-rabbit IgG. Nomarski 
DIC imaging on a portion of each field demonstrates the 
membrane integrity of both erythrocytes and infected leuko-
cytes (insets) (bar = 20 μm). (C) Western blot hybridization 
analysis probing for bovine IgG was performed on 
renografin-purified C. trachomatis EBs (EBs) and lysates from 
uninfected (Uninf.) and infected cultures (Ser K). Cell lysates 
were matched to ensure equal numbers of cells per lane 
(~2.0 × 107 cells/mL) and purified EBs were diluted to the 
same IFU/mL as the infected the cell lysate (~1 × 106IFU/mL).BMC Microbiology 2008, 8:213 http://www.biomedcentral.com/1471-2180/8/213
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Bovine serum albumin does not accumulate within infected cells Figure 4
Bovine serum albumin does not accumulate within infected cells. Cells infected for 48 h with C. trachomatis serovar K 
(guinea pig anti-Chlamydia/TRITC-conjugated goat anti-guinea pig)(A) were probed for internalized BSA using a rabbit anti-BSA 
antibody and detected with FITC-conjugated goat anti-rabbit Ig (B). Unlike IgG, this abundant ~66 kDa polypeptide does not 
accumulate within the chlamydial inclusion, as apparent in the merge of Chlamydia and nuclear stains (C). A merge incorporat-
ing DIC imaging shows an identifiable inclusion and indicates no co-localization of the two immunolabels has occurred (D). This 
demonstrates that BSA is not subject to the same entry or sequestration as bovine IgG, indicative that the process of IgG inter-
nalization is selective. (bar = 10 μm).BMC Microbiology 2008, 8:213 http://www.biomedcentral.com/1471-2180/8/213
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achieve them by means of a receptor-mediated process
and research in this area is in progress.
Fluorescently-labeled antibodies are subject to 
sequestration
Despite appropriate controls, the use of secondary anti-
bodies for indirect staining can result in misleading, arti-
factual findings. In light of this concern, monitoring the
uptake of a FITC-labeled IgG can eliminate the risk of
cross-reactivity and non-specific binding by the secondary
antibody, both inherent with the indirect technique. The
cells were only exposed to FITC-labeled IgG in their
growth medium prior to fixation then, after extensive rins-
ing as described in the methods, monolayers were perme-
abilized and stained for Chlamydia  with a TRITC-
conjugated secondary antibody. Importantly, at no point
after the cells were permeabilized did they come in con-
tact with FITC-labeled IgG. Epi-fluorescent microscopy of
J774A.1 cells with intact nuclei (Fig. 5A), when infected
with C. trachomatis serovar K (Fig. 5B), exhibit intra-inclu-
sion accumulation of the FITC-labeled IgG (Fig. 5C) fol-
lowing its addition to the culture media. These labeled
molecules are present in detectable but minimal levels
throughout the cytosol of uninfected cells shown in the
same field. Nomarski DIC imaging indicates that both
uninfected and infected cells appear otherwise healthy
and possess intact plasma membranes (Fig. 5D). Monitor-
ing the uptake of FITC- labeled molecules effectively
addresses concerns regarding antibody promiscuity and
other artifacts of post-fixation manipulation. In addition,
this technique provides further validation of the experi-
ments presented above that show bovine IgG uptake and
accumulation within the inclusion. The same experiment
was also performed without indirect immunolabeling of
Sequestration of pre-labeled IgG within the chlamydial inclusion Figure 5
Sequestration of pre-labeled IgG within the chlamydial inclusion. Cells infected with C. trachomatis serovar K were 
incubated at 24 hpi with FITC-labeled IgG and fixed 1 h later. Visualization of DNA using DAPI (A) confirms that the J774A.1 
macrophages are intact and robust. Rabbit anti-Chlamydia antibodies labeled with TRITC-conjugated anti-rabbit IgG (B) shows 
a well-developed inclusion while accumulation of FITC-labeled IgG (C) within it is readily apparent. A merge of images A-C 
with a DIC micrograph (D) shows the cells are generally healthy during infection. (E) Cells that were similarly exposed to 
FITC-labeled IgG but were not permeabilized, show sequestration of the labeled IgG. In this absence of anti-Chlamydia staining 
DIC imaging and DAPI were used to identify infected cells. (F) Chlamydia-infected cells were also incubated with FITC-labeled 
F(ab')2 fragments. These cells exhibit no intracellular accumulation of this fluorescent label. (bar = 10 μm).BMC Microbiology 2008, 8:213 http://www.biomedcentral.com/1471-2180/8/213
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Chlamydia or cell membrane permeabilization. Instead,
the inclusion was identified using DAPI labeling and
Nomarski imaging after fixation with paraformadehyde,
avoiding permeabilization of cell membranes. These con-
trol measures confirm that green fluorescence detected
within the inclusion pictured in Fig. 5E is not an artifact of
staining and results from the uptake of FITC-labeled IgG.
An additional control experiment was designed to assess
whether translocation requires a structurally complete IgG
molecule. FITC-labeled F(ab')2 fragments were similarly
added to the supernatant of infected cultures. Unlike
intact IgG molecules, these F(ab')2 fragments failed to
enter the inclusion as evident in Figure 5F. The exclusion
of F(ab')2 molecules from the inclusion suggests the Fc
region of the IgG molecule, which these fragments lack, is
necessary for the observed sequestration. These data, in
addition to results obtained when probing for intracellu-
lar BSA, indicate the observed IgG uptake is not a result of
porous membranes, structural damage, or mass transport.
Verification of IgG sequestration during infection of non-
phagocytic cell lines
J774A.1 murine macrophages have been used for the
majority of IgG uptake characterization, their phagocytic
nature making them useful cells for chlamydial research
due to their susceptibility to infection. However, as shown
in Figure 6, IgG sequestration within the inclusion also
occurs in other established cell lines such as HEp-2 and
McCoy.
The human epidermoid carcinoma cell line HEp-2, which
is commonly used in chlamydial and viral research, was
evaluated for the presence of IgG within the inclusions of
infected cells. Epi-fluorescent microscopy again indicates
that exogenous bovine IgG is co-localized with the inclu-
sions of infected HEp-2 cells (Fig. 6A) and the distribution
of staining was indistinguishable from that of J774A.1
cells. A second immortalized cell line, the McCoy cell, has
traditionally been utilized for in vitro cultivation of C. tra-
chomatis[16]. This mouse fibroblast line is readily infected
and hardy throughout the course of chlamydial develop-
ment. These cells were similarly infected with C. trachom-
atis serovar K and, as with the other cell lines evaluated,
epi-fluorescence microscopy indicated the presence of IgG
within the inclusion (Fig. 6B). Although not shown, all
cell types were also evaluated with confocal microscopy
and the observed IgG sequestration was confirmed in all
instances. Taken together, results from the examination of
different cell lines suggest that this phenomenon could
IgG sequestration occurs in multiple cell lines Figure 6
IgG sequestration occurs in multiple cell lines. Non-phagocytic cells infected for 48 hpi were evaluated for the presence 
of bovine IgG within the chlamydial inclusion. Human epidermal HEp-2 (A), and mouse fibroblast McCoy (B) cell lines were 
evaluated by epi-fluorescence (1000×) and both were found to exhibit co-localization (yellow) of bovine IgG (detected with 
FITC-conjugated goat anti-bovine IgG, green) and the chlamydial inclusion (rabbit anti-Chlamydia/TRITC-conjugated goat anti-
rabbit IgG, red), thus indicating that IgG has been translocated to the inclusion in these cell lines as well. (bar = 10 μm).BMC Microbiology 2008, 8:213 http://www.biomedcentral.com/1471-2180/8/213
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affect a variety of cell and tissue types within the infected
host, including cells of the endothelium, epithelium, and
blood.
Discussion
Historically the chlamydial inclusion has been viewed as
an isolated, inaccessible vesicle within the host cell. Many
host-pathogen interactions remain undefined and only a
limited number of host-derived molecules are known to
be co-opted by chlamydial organisms and stored within
this compartment. In addition, the function and conse-
quences of their sequestration remain unclear in some
cases. Possible effects of sequestering these molecules
include immune evasion, fulfillment of physiological
requirements, or facilitating enhanced inclusion develop-
ment. Further questions arise because molecules known
to accumulate within the inclusion share little in common
with one another. These include host polypeptides
involved in cell-cell adhesion and cytoskeletal structures,
cell membrane components, and eukaryotic phospholip-
ids[17]. Examples of these diverse molecules include β-
catenin, sphingomyelin, intermediate filament proteins,
and cholesterol[7,8,10,18]. The limited number but
diverse nature of macromolecules that are sequestered
within the inclusion implies that the removal of these
host components may also have an impact on cell or tis-
sue function, resulting in sequelae that appear unrelated
to infection.
With the exception of exogenous cholesterol, the intra-
inclusion sequestration of moieties derived from the
extracellular environment of the host cell is yet to be
reported[18]. The experiments described have provided
evidence that extracellular IgG is among the proteins now
known to be sequestered within the inclusion. To our
knowledge, application of FITC-labeled IgG to the culture
media has allowed for the first successful demonstration
of non-invasive, direct targeting of developing inclusions
with an exogenous molecule, a capability that could give
rise to novel therapeutics. The data presented suggest the
uptake of IgG to be a selective, directed phenomenon as
opposed to a non-discriminatory influx of molecules
resulting from phagocytic or pinocytic events. It is also
clear that this process occurs throughout the normal
course of infection, a factor that could indicate its impor-
tance to chlamydial development. Previously unreported
with other intracellular pathogens, these features make
IgG uptake and accumulation a unique aspect of chlamy-
dial infections and one requiring further characterization.
A more thorough understanding of this phenomenon will
result in unprecedented access to this privileged compart-
ment, including innovative methods of detection and
treatment. A macrolide-IgG conjugate, for instance, would
theoretically result in an accumulation of bacteriocidal
compound inside the pathogen-containing compart-
ment[19].
Entry and intracellular accumulation of exogenous pro-
teins can be a result of various mechanisms. Phagocytosis,
fluid-phase endocytosis, and internalization during
chlamydial entry are non-specific mass transport proc-
esses that might lead to the events observed. If this were
the case then it would also lead to a detectable influx of
BSA into the cell. However, the absence of the smaller,
more abundant BSA from the inclusion rules out involve-
ment of non-specific mechanisms for IgG uptake. These
findings suggest that entry of IgG is a selective process,
possibly a receptor-mediated phenomenon.
The specificity of this sequestration is further emphasized
by results obtained using directly-labeled fluorescent mol-
ecules to track the uptake of IgG. The accumulation of
FITC-labeled IgG and exclusion of FITC-labeled F(ab')2
fragments indicate that all or part of the IgG Fc region is
necessary for the observed translocation of the molecule
and excludes Ig association with EBs as the key mecha-
nism for entry. These findings support a role for host cell
Fc receptors in the mechanism of IgG entry and, along
with the exogenous nature of IgG, distinguishes this phe-
nomenon from other examples of host cell-derived pro-
tein translocation to the chlamydial inclusion. The
experiments using fluorescently-labeled whole IgG mole-
cules indicate that accessing and labeling of the inclusion
without fixation or permeabilization may be possible.
IgG internalization within the inclusion is also clearly not
restricted to phagocytic cells. As professional phagocytes,
it is reasonable that J774A.1 cells would be more likely to
acquire IgG from the extracellular environment, possibly
leading to its sequestration within the inclusion. How-
ever, the results obtained during tests for the same phe-
nomenon in HEp-2 and McCoy cells demonstrate that
IgG uptake and accumulation occurs with non-phagocytic
cells as well, and with seemingly indistinguishable effi-
ciencies. It is also observed that this occurs with all
infected cells in these cultures, making intra-inclusion IgG
sequestration a ubiquitous phenomenon in the cell lines
tested. The demonstration that this can occur in diverse
cell types in vitro suggests it could play an important role
in a variety of tissues during chlamydial infection in a
human host. Given the various of cell types shown to
exhibit IgG uptake during infection, this could potentially
impact Ig levels in the interstitial space surrounding
infected cells in vivo, ultimately compromising host
immune defenses at sites of infection.
Western blot hybridization data has demonstrated that
IgG breakdown products are present at high concentra-
tions in infected cells, supporting the theory that this pro-BMC Microbiology 2008, 8:213 http://www.biomedcentral.com/1471-2180/8/213
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tein is being degraded. As large, globular proteins that are
widely distributed throughout most mammalian tissues,
Ig molecules would represent an abundant source of
amino acids, should breakdown and subsequent assimila-
tion by Chlamydia occur. This is not without precedent
among agents of infectious disease. A number of bacterial
pathogens, including species of Neisseria,  Haemophilus,
and  Streptococcus, produce well-characterized proteases
catalyzing the hydrolysis of human IgA, an important vir-
ulence factor during infection[20,21]. It is also known
that several bacterial species contain IgG pro-
teases[22,23]. In addition, at least one eukaryotic organ-
ism, the pork tapeworm Taenia solium, is capable of
converting these immune molecules to a supplemental
nutrient source through the use of an IgG protease [24].
Given the existence of homologous bacterial proteases
and a eukaryotic system in which the pathogen is known
to exploit IgG for its own metabolic needs, the uptake and
degradation of IgG by Chlamydia  to enhance nutrient
availability would not be unique to this organism. Fur-
ther, should antibodies be found to constitute a substrate
of chlamydial physiology, it would provide a possible
rationale for the increased non-specific, polyclonal anti-
body production by B cells in response to the presence of
chlamydial organisms, as demonstrated in early work by
Bard and Levitt[25]. For these reasons, a thorough evalua-
tion of whether Ig breakdown products are being used for
chlamydial metabolism will be necessary and may pro-
vide additional insight into chlamydial physiology and
host cell interaction.
It is clear that the translocation reported here is distinct
from the previously described examples of host protein
uptake into the inclusion and further studies will be
required to define the mechanisms of initiation and to
assess the fate of sequestered IgG. This phenomenon has
not been previously reported with any intracellular path-
ogen, suggesting that Ig uptake and accumulation may be
a unique characteristic of Chlamydia. Additionally, under
experimental conditions, this phenomenon has shown
promise as a means of targeting the inclusion in a direct
and specific manner. This would provide a valuable new
tool for studies of Chlamydia both in vivo and in vitro, rel-
evant because of the pathogen's prevalence and significant
impact on public health. A more complete understanding
of host Ig sequestration should provide new insights
regarding the detection, evaluation, and treatment of
chlamydial infections.
Conclusion
Results obtained from these studies demonstrate intra-
inclusion IgG sequestration as a newly observed character-
istic of Chlamydia-infected cells. Evidence from these stud-
ies support the follow conclusions: i) IgG, initially present
only in the media surrounding the host cell, is translo-
cated to the inclusion of infected cells but shows minimal
internalization by uninfected cells, consistent with the
basal level of uptake that is involved in Ig homeosta-
sis[26]. ii) The localization of IgG is within the inclusion
compartment itself. iii) The observed translocation of IgG
is specific for this particular extracellular protein. iv)
Whole IgG is necessary for uptake since antibodies pre-
labeled with fluorescein are subject to the sequestration
while pre-labeled F(ab')2 fragments are not. v) IgG seques-
tration occurs in a variety of cell types and is therefore not
unique to phagocytic cells such as the J774A.1 line exam-
ined initially. Under the conditions tested, significant
accumulation of IgG is dependant on the presence of C.
trachomatis or C. pneumoniae organisms in the host cell.
These in vitro microscopy studies were validated with the
detection of IgG sequestration in human blood donor
samples and by western blot of infected cultures.
Together, the findings introduce a unique characteristic of
cells infected with Chlamydia, both in vitro and in vivo, and
might also have implications for pathogenesis and treat-
ment of these diseases.
It is too early to conclude the precise mechanism(s) lead-
ing to sequestration of IgG within the chlamydial inclu-
sion. Although it is likely that this phenomenon is the
result of combined bacterial and host cell processes, the
molecular and cellular function of this pathogen-host
interaction remains to be clarified. This report, while pos-
sibly indicative of host cell Fc receptor involvement in IgG
uptake, is only intended to describe the previously unre-
ported presence of exogenous IgG within the chlamydial
inclusion. Ongoing studies are designed to further charac-
terize the mechanisms driving this sequestration from the
perspective of both the eukaryotic host cell and the path-
ogen. Given its occurrence in vivo and the potential appli-
cations for drug delivery, detection, and genetic
manipulation of chlamydial organisms, future examina-
tions of IgG sequestration will likely provide important
tools and valuable knowledge in the context of chlamy-
dial infections and their treatment.
Methods
Cell Culture
Prior to inoculation, cells were grown in Richter's
Improved Minimal Essential Medium with Insulin
(IMEMZO)(Irvine Scientific, Santa Ana, CA) supple-
mented with 10% FBS (Atlanta Biologicals, Norcross, GA)
at 37°C and 5% CO2. J774A.1, HEp-2, and McCoy cells
were seeded on 12 mm glass coverslips and grown until
~80% confluent for infection, staining, and visualization.
Infection of host cells
For all infections, whole cell lysate in sucrose phosphate
glutamate buffer (SPG) of J774A.1 cells infected with C.
trachomatis serovar K/UW-31Cx was diluted 1:100 from aBMC Microbiology 2008, 8:213 http://www.biomedcentral.com/1471-2180/8/213
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stock inoculum in Cycloheximide Overlay Medium
(COM) (Cambrex Bio Science, Walkersville, MD) supple-
mented with 10% FBS. This inoculum was incubated with
cells for 3 h at 37°C, removed, and replaced with fresh
COM/FBS for further incubation. Cell monolayers, with
the exception of those used for Fig. 5E, were fixed and per-
meablized for 10 minutes with 70% cold MeOH to facili-
tate immunostaining.
Immunostaining
After removing MeOH, slides and coverslips were washed
3× with PBS prior to staining. All antibodies were diluted
in PBS (pH 7.2) then placed in 300 μL and 500 μL aliq-
uots on coverslips and slides, respectively. Incubations
were performed in the dark for 1 h at room temperature.
Detection of chlamydial organisms infecting J774A.1,
HEp-2, and McCoy cells was performed using a rabbit
anti-C. trachomatis polyclonal antibody (Biodesign, Saco,
ME) diluted 1:100. Binding of anti-Chlamydia antibodies
was detected with a tetramethyl-rhodamine isothiocy-
anate (TRITC)-conjugated goat anti-rabbit IgG (H+L) sec-
ondary antibody (Jackson ImmunoResearch, South
Windham, ME) diluted 1:100. Additional confirmatory
immunostaining was obtained by using a mouse mono-
clonal anti-chlamydial LPS antibody (BioDesign, clone
BDI815) followed by a TRITC-conjugated goat anti-
mouse IgG (H+L) (Jackson ImmunoResearch, South
Windham, ME), both diluted 1:100. For detection of
sequestered bovine IgG in J774A.1, HEp-2, and McCoy
cells a FITC-conjugated F(ab')2 fragment anti-bovine IgG
(H+L) (Jackson ImmunoResearch, South Windham, ME)
was used at a 1:100 dilution. BSA labeling on permeabi-
lized, infected J774A.1 cells was performed using a 1:200
dilution of rabbit anti-bovine albumin polyclonal anti-
body (Pel-Freez Biologicals, Rogers, AR) followed by a
1:100 dilution of FITC-labeled goat anti-rabbit IgG poly-
clonal antibody (Jackson ImmunoResearch, South Wind-
ham, ME). Chlamydia staining during the BSA experiment
was performed using pre-diluted guinea pig anti-Chlamy-
dia antibody (Biomeda Corp., Hayward CA) followed by
a 1:100 dilution of TRITC-conjugated goat anti-guinea pig
IgG (Jackson ImmunoResearch, South Windham, ME).
All coverslips and slides were mounted with VectaShield
DAPI-containing mounting media (Vector Laboratories
Inc., Burlingame, CA).
Detection of sequestered IgG in human leukocytes
A 30 μL aliquot of a fraction from whole blood enriched
for leukocytes from two individuals confirmed to be
infected with Chlamydia sp. and collected during a separate
large-scale study of human donor blood[14], was smeared
on a glass slide and stained for evaluation of IgG seques-
tration in vivo. The sample was preserved in ethylenedi-
aminetetraacetic acid (EDTA) and was fixed and
permeabilized with 70% cold MeOH. Labeling of the
inclusion was achieved using the using the same staining
protocol described for in vitro experiments. Human IgG
was immunostained using a mouse monoclonal antibody
specific for the human Fc fragment of IgG (Pel-Freez Bio-
logicals, Rogers, AR), diluted 1:1000, followed by a 1:100
dilution of FITC-conjugated goat anti-mouse antibody
(Jackson ImmunoResearch, South Windham, ME), both
for 1 h at RT.
Demonstration of uptake using labeled IgG
IgG translocation and accumulation inside the inclusions
of infected cells was tracked using commercially-prepared,
pre-labeled immunoglobulin. At 24 hpi a 1:100 dilution
of FITC-conjugated goat anti-human IgG (H+L) or FITC-
conjugated F(ab')2 fragment rabbit anti-horse IgG (H+L)
was added to the media of infected cells, which consisted
of COM supplemented with 10% FBS. Coverslips were
fixed 1 h later with 70% cold MeOH then stained for DNA
and Chlamydia as described. Control cells were fixed with
0.1% paraformaldehyde after media removal and thor-
ough rinsing, then mounted with DAPI-containing
VectaShield.
Confirmation of intracellular IgG by western blot 
hybridization
A 75 cm2 culture flask of J774A.1 cells infected with C. tra-
chomatis serovar K and one mock infected flask, all at 80%
confluence, were treated with 0.25% trypsin from porcine
pancreas (Sigma-Aldrich Inc., St. Louis, MO) until cells
had lifted, centrifuged at 550 × g for 5 minutes, and resus-
pended in 1 mL of PBS (pH 7.2) per treatment (~2 × 107/
mL cells for each treatment). Infected and uninfected cell
preparations were lysed and treated with deoxyribonucle-
ase I (Sigma-Aldrich Inc., St. Louis, MO) and ribonuclease
A (Sigma-Aldrich Inc.), both used at 50 μg/mL for 4 h at
37°C. Purified EBs were diluted to match the IFU of
infected cell lysate (~1 × 106 IFU/mL). After mixing with
2× non-reducing sample buffer (50% ddH2O, 12.5% 0.5
M tris-HCl pH 6.8, 10% glycerol, 2.5% bromophenol
blue, 2.0% SDS), 20 μL of each preparation was electro-
phoresed using a 10–20% Tricine SDS-PAGE (Invitrogen
Corp., Carlsbad, CA) and transferred to Immobilon-P
0.45 μm PVDF membrane (Millipore Corp., Bedford, MA)
at 80 V for 1 h. Membrane was blocked with nonfat dry
milk, 6% in ddH20, for 3 h, rinsed 3× with PBS, and
probed with an alkaline phosphatase-conjugated rabbit
anti-bovine IgG polyclonal antibody (Jackson Immu-
noResearch, South Windham, ME) at a 1:1000 dilution
for 1 h at RT. After washing 3× with PBS the membrane
was developed with Sigma Fast 5-bromo-4-chloro-3-
indolyl phosphate/nitroblue tetrazolium (BCIP/NBT)
tablets (Invitrogen Corp., Carlsbad, CA) for 15 min before
washing with dH2O and allowing to dry.BMC Microbiology 2008, 8:213 http://www.biomedcentral.com/1471-2180/8/213
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Microscopic analysis
Confocal microscopy on adherent monolayers and
smeared blood samples was performed using an LSM 510
Meta Confocal Microscope at 630× magnification (Carl
Zeiss AG, Oberkochen, Germany). The Z-series presented
in Figure 2 contains optical sections, acquired in sequen-
tial 1.0 μm increments with a thickness of 0.5 μm,
throughout the Z-axis of the cells. Epi-fluorescent micros-
copy was performed at 400× or 1000× using a Nikon Spot
epi-fluorescent microscope (Nikon, Tokyo, Japan) with
Spot-RT camera system (Diagnostic Imaging). Both
instruments were used for Differential Interference Con-
trast (DIC) imaging.
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Additional File 1
Indirect immunostaining control. In addition to using indirect immu-
nolabeling of cultured cells for both Chlamydia and IgG in Figures 1, 2, 
and 6, controls were stained with only the anti-Chlamydia antibody. Epi-
fluorescent microscopy shows no green FITC signal to be detectable when 
DAPI, FITC, and TRITC channels are merged. This demonstrates that 
IgG apparent within the inclusion is not the result of anti-Chlamydia 
antibody cross-reactivity. Additionally, this excludes spectral overlap of 
TRITC detectable in the FITC emission spectrum as the cause of the 
reported findings.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2180-8-213-S1.jpeg]
Additional File 2
Staining controls on in vivo samples. Blood samples from human 
donors known to be infected with Chlamydia were assessed for IgG accu-
mulation within leukocytes. Staining controls were performed in order to 
assess the cross-reactivity and spectral overlap of the antibodies used. 
Blood from the same samples shown in Figure 3 was also stained only for 
Chlamydia (A) or IgG (B). Given the absence of any green coloration, 
merged images of the detected signals in DAPI, FITC, and TRITC emis-
sion ranges indicate that spectral overlap into the FITC channel is not 
occurring.
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